News: Bed Bath & Beyond Inc (BBBY.O)

BBBY.O on Nasdaq

63.70USD
17 Apr 2014
Price Change (% chg)

$-0.84 (-1.30%)
Prev Close
$64.54
Open
$64.58
Day's High
$64.74
Day's Low
$63.32
Volume
3,156,659
Avg. Vol
2,855,620
52-wk High
$80.82
52-wk Low
$62.12

Search Stocks
Select another date:

Thu, Apr 10 2014

US STOCKS-Nasdaq has worst day since June 2012, weighed again by biotechs

* Indexes off: Dow 1.2 pct, S&P 1.6 pct, Nasdaq 2.7 pct (Updates to afternoon trading)

UPDATE 1-US STOCKS-Wall St dips after rally; biotechs drag Nasdaq

* Indexes off: Dow 0.72 pct, S&P 1.14 pct, Nasdaq 2.19 pct (Adds context, updates prices)

US STOCKS-Wall St dips after rally; biotechs drag Nasdaq

* Indexes off: Dow 0.17 pct, S&P 0.37 pct, Nasdaq 1.13 pct (Updates to open, adds quote)

US STOCKS-Wall St to dip at open after rally, soft earnings

* Futures off: Dow 19 pts, S&P 2.25 pts, Nasdaq 5.25 pts (Adds data, updates prices)

US STOCKS-Futures flat with initial claims data on tap

NEW YORK, April 10 - U.S. stock index futures were little changed on Thursday, after the S&P 500 notched its biggest gain in over a month, as investors digested the opening round of earnings season and looked to data on the labor market.

US STOCKS-Wall St finishes flat on caution before U.S. jobs data

* Telecom stocks sag; AT&T, Verizon are Dow's top decliners

US STOCKS-Wall St ends flat on caution before U.S. jobs data

* Telecom stocks weigh; AT&T, Verizon are Dow's top decliners

US STOCKS-Wall Street little changed in choppy session

* Intercept Pharma drug meets goal in trial, shares triple

US STOCKS-Wall Street loses steam as retailers, Exxon weigh

* Intercept Pharma drug meets goal in trial, shares triple

Bed Bath & Beyond cuts full-year earnings forecast

- Home furnishings retailer Bed Bath & Beyond Inc cut its full-year earnings forecast due to a lowered sales expectation and weakening margins, sending its shares down 9 percent after the bell.

Select another date:
Search Stocks